X

Trial Profile

Evaluating Safety and efficacy in retrospective ANAlysis after switching Drug to topiroxostat Among patients with hyperuricemia study

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 16 Sep 2019

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Topiroxostat (Primary)
Indications Hyperuricaemia
Focus Therapeutic Use
Acronyms SANADA

Most Recent Events

09 Sep 2019 Results to evaluate the effects of topiroxostat on circulating lipid concentrations in hyperuricemic patients published in the International Journal of Clinical Pharmacology and Therapeutics
10 Feb 2018 Status changed from active, no longer recruiting to completed.
12 Aug 2017 Status changed from recruiting to active, no longer recruiting.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com